China National Accord Medicines Corp Ltd
SZSE:000028
China National Accord Medicines Corp Ltd
Revenue
China National Accord Medicines Corp Ltd
Revenue Peer Comparison
Competitive Revenue Analysis
Latest Figures & CAGR of Competitors
Company | Revenue | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
C
|
China National Accord Medicines Corp Ltd
SZSE:000028
|
Revenue
¥75.5B
|
CAGR 3-Years
8%
|
CAGR 5-Years
12%
|
CAGR 10-Years
14%
|
Sinopharm Group Co Ltd
HKEX:1099
|
Revenue
¥591.6B
|
CAGR 3-Years
11%
|
CAGR 5-Years
12%
|
CAGR 10-Years
15%
|
|
S
|
Shanghai Pharmaceuticals Holding Co Ltd
SSE:601607
|
Revenue
¥260.3B
|
CAGR 3-Years
11%
|
CAGR 5-Years
10%
|
CAGR 10-Years
13%
|
Jointown Pharmaceutical Group Co Ltd
SSE:600998
|
Revenue
¥151.8B
|
CAGR 3-Years
13%
|
CAGR 5-Years
13%
|
CAGR 10-Years
17%
|
|
C
|
China National Medicines Corp Ltd
SSE:600511
|
Revenue
¥49.7B
|
CAGR 3-Years
7%
|
CAGR 5-Years
5%
|
CAGR 10-Years
17%
|
Huadong Medicine Co Ltd
SZSE:000963
|
Revenue
¥40.3B
|
CAGR 3-Years
7%
|
CAGR 5-Years
6%
|
CAGR 10-Years
10%
|
See Also
What is China National Accord Medicines Corp Ltd's Revenue?
Revenue
75.5B
CNY
Based on the financial report for Dec 31, 2023, China National Accord Medicines Corp Ltd's Revenue amounts to 75.5B CNY.
What is China National Accord Medicines Corp Ltd's Revenue growth rate?
Revenue CAGR 10Y
14%
Over the last year, the Revenue growth was 3%. The average annual Revenue growth rates for China National Accord Medicines Corp Ltd have been 8% over the past three years , 12% over the past five years , and 14% over the past ten years .